Elenco degli articoli con argomento «dermatite atopica»
Dermatologia13 dic 2022
Comparison of real-world treatment outcomes of systemic immunomodulating
Few data exist on differences in treatment effectiveness and safety in atopic dermatitis patients of different skin types.
07 dic 2022
Tralokinumab treatment improves the skin microbiota by increasing the microbial diversity in adults
Atopic dermatitis (AD) is characterized by microbial dysbiosis, immune dysregulation, and an impaired skin barrier.
31 ott 2022
Effectiveness and tolerance of Janus kinase inhibitors
Effectiveness and tolerance of Janus kinase inhibitors for the treatment of recalcitrant atopic dermatitis in a real-life French multicenter adult cohort
31 ott 2022
Association of atopic dermatitis with new-onset migraine
Association of atopic dermatitis with new-onset migraine: A nationwide population-based cohort study
24 ott 2022
The effects of systemic immunomodulatory treatments on COVID-19
Limited data are available on the effects of systemic immunomodulatory treatments on COVID-19 outcomes in patients with atopic dermatitis (AD).
03 ott 2022
Dupilumab in children aged 6 months to younger than 6 years
Background Current systemic treatments for children younger than 6 years with moderate-to-severe atopic dermatitis
28 set 2022
Con nuove terapie più qualità vita pazienti e risparmi per SSN
Non solo prurito e bruciore della pelle a volte così intensi da impedire di concentrarsi sul lavoro o a scuola, dormire e avere rapporti sociali sereni
28 set 2022
Atopic dermatitis and risk of major neuropsychiatric disorders in children
Paediatric atopic dermatitis (AD) has been linked to neuropsychiatric comorbidities
19 set 2022
Eczema European guideline part II
The evidence- and consensus-based guideline on atopic eczema
19 set 2022
Eczema European guideline part I
The evidence-and consensus-based guideline on atopic eczema was developed in accordance with the EuroGuiDerm Guideline
19 set 2022
Nuove terapie migliorano qualità della vita e fanno risparmiare.
Con le nuove terapie, però, si aprono nuovi scenari, per i pazienti e per il Ssn
27 giu 2022
Probiotics for the prevention of atopic dermatitis
BackgroundAtopic dermatitis (AD) is a common skin disease during infancy
22 giu 2022
La gestione dei pazienti con dermatite atopica
Monografia SIDeMaST
23 mag 2022
Subtypes of atopic dermatitis
Atopic dermatitis (AD) is a heterogenous disorder and can be classified into different types.
16 mag 2022
Contact allergy in children with and without atopic dermatitis
Contact allergy and atopic dermatitis (AD) are both common inflammatory T cell-mediated diseases and many factors may influence the prevalence of contact allergy in AD patients
09 mag 2022
Moderate-to-severe atopic dermatitis in adolescents
Moderate-to-severe atopic dermatitis (AD) in the adolescence is a high burden disease and its treatment can be very challenging
14 mar 2022
Efficacy and Safety of Upadacitinib in Patients With Moderate to Severe Atopic Dermatitis
Primary results from the Measure Up 1 and Measure Up 2 studies demonstrated upadacitinib efficacy and safety through 16 weeks in patients with atopic dermatitis.
07 feb 2022
Increased expression of Filaggrin and Claudin-1 in the ocular surface
Atopic dermatitis (AD) is an itchy, chronic and inflammatory skin condition, with dysfunctional immune response and skin barrier defects.
31 gen 2022
The Impact of Childhood Atopic Dermatitis
The Impact of Childhood Atopic Dermatitis on Life Decisions for Caregivers and Families
20 dic 2021
Atopic dermatitis associated with autoimmune, cardiovascular and mental health comorbidities
Previous studies have reported conflicting estimates of associations between atopic dermatitis (AD) and autoimmune, cardiovascular and mental health comorbidities.